Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,096 | -15,265 | -30,698 | -34,016 | -769 |
| Depreciation Amortization | 377 | 268 | 151 | 73 | 198 |
| Accounts receivable | -9 | -4 | -1 | 0 | -5 |
| Accounts payable and accrued liabilities | 73 | 13 | -61 | -68 | 10 |
| Other Working Capital | 80 | -42 | -124 | -65 | 304 |
| Other Operating Activity | 10,830 | 13,520 | 29,635 | 33,482 | -617 |
| Operating Cash Flow | $-1,745 | $-1,511 | $-1,098 | $-594 | $-878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -35 | -30 | -10 | -6 |
| Other Investing Activity | -255 | -243 | -151 | -29 | 0 |
| Investing Cash Flow | $-294 | $-277 | $-181 | $-39 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,394 | 2,034 | 1,515 | 730 | 997 |
| Debt Repayment | -265 | -201 | -185 | -95 | -163 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 50 |
| Financing Cash Flow | $2,129 | $1,833 | $1,329 | $635 | $884 |
| End Cash Position | 91 | 45 | 51 | 2 | N/A |
| Net Cash Flow | $91 | $45 | $51 | $2 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,745 | -1,511 | -1,098 | -594 | -878 |
| Capital Expenditure | -39 | -35 | -30 | -10 | -6 |
| Free Cash Flow | -1,784 | -1,546 | -1,128 | -604 | -884 |